Skip to main content
LibraryFamily 17 · Research & Clinical Trials

Clinical trial recruitment matching

CuratedPilotEmerging evidence

Reviewed for completeness and published to the Library.

Screens structured records and clinical notes against trial eligibility criteria to surface a ranked list of candidate patients for the research team.

Plain-language summary

AI

Choose an audience and generate a tailored summary on demand. The AI uses only what is on this page.

Clinical context
Clinical problem
Discover a research insight
Point of care
Back office
Nature of AI output
A prioritised list
Clinical specialty
Oncology
Care setting
Back office
Patient population
Patients potentially eligible for open oncology clinical trials at the cancer centre.
Intended use
Screens structured records and clinical notes against trial eligibility criteria to surface a ranked list of candidate patients for the research team.
Technology
AI technique
NLP / large language model, Classical machine learning
Input data
Structured EHR data, Clinical notes / free text
Output type
Prioritisation / schedule
Autonomy level
Informs a human (advisory)
Model provenance
Research model
Model version
Built on a general-purpose model
Yes
Deployment
Status
Pilot
Country
Netherlands
Deployment date
1 February 2025
Sites
1
Regulatory & governance
EU AI Act risk tier
Minimal risk
High-risk basis
Not applicable
Medical device
No
EU MDR class
Not a device
CE marking
Not required
FDA status
Not applicable
ISO 14971 risk class
Low
GDPR processing basis
Public interest
GDPR DPIA
Completed
Data identifiability
Pseudonymised
Explainability method
Post-hoc
Human oversight model
The research team verifies eligibility and obtains consent; AI only prioritises candidates.
NICE evidence standards
ESF tier
Tier A — system / service
Evidence category
Performance summary
Headline metric
Positive predictive value
Value
0.74
Subgroup performance assessed
No
Known bias signals

Similar deployments

AI
Looking for close matches in the Library…

Evidence records

Studies and evaluations attached to this use case.

  • Retrospective validation

    Positive predictive value: 0.74

    Population: Oncology trial screening cohort

Contributors

Deploying organisation
[demo] Erasmus MC · Hospital / health system · Netherlands
AI vendor
[demo] TU Delft — AIH Lab · Netherlands
Product name